Stepan Company
SCLBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeStepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland,. With a market capitalization of $1.20B, it sits in small-cap territory. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Market Cap
$1.20B
Beta
0.95
P/E (TTM)
—
P/E (Fwd)
13.45
EPS (TTM)
$-0.62
EPS (Fwd)
$3.92
ROE
-1.2%
ROA
1.5%
Cash
$140.8M
Total Debt
$713.1M
Free CF
$44.4M
52W Change
-3.3%
Annual Financials
Cash vs Debt
The company holds $140.8M in cash, though total debt stands at $713.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $44.4M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -1.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.5% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $2.77B (2022) to $2.33B (2025), a 16% decline worth watching.
Stepan Company carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SCL.